A broad Q2 acceleration drove a top-line and EBITDA beat, but management paired a higher local-currency sales range with a lower percentage-margin range while protecting the absolute EBITDA outlook.
H1 sales of CHF5.59 billion were about 3% above consensus; implied Q2 local-currency growth of 6.8% and organic growth of 5.7% were far above expectations of roughly 1.7% and 0.6%. EBITDA of CHF1.06 billion beat consensus by about 4%, and the 19.0% margin was roughly 20 basis points ahead despite cost inflation. Management raised local-currency sales growth to 3–6% from 1–4% but cut the EBITDA-margin range to 19.0–19.5% from 19.5–20.0%.
The sales range increased by two percentage points at both ends, the margin range fell by 50 basis points, and management said it was comfortable with absolute EBITDA consensus around CHF2.16 billion. Fast Forward savings remained on track and MBCC integration was declared complete.
The sales range implies roughly 2%, 5% or 8% local-currency growth in H2 at the low end, midpoint and high end. The margin range implies an H2 margin near 19%, 19.5% or 20%, versus 19.0% in H1 and roughly 18% in H2 2025.
A completed closing-price reaction was not yet available. The setup pits a much stronger organic-sales trajectory and protected CHF EBITDA against the optical margin cut and evidence that price is doing more work than volume.
The central question is no longer whether Sika can return to growth, but whether pricing-led growth can convert into volume, percentage-margin expansion and a durable re-rating as China remains weak.
The direct read-through was to organic growth, the volume contribution, price realization and material margin. The key question shifted from demand survival to the quality of the growth mix.
[AS-ME-024]A broad Q2 acceleration drove a top-line and EBITDA beat, but management paired a higher local-currency sales range with a lower percentage-margin range while protecting the absolute EBITDA outlook.
Organic growth and Asia materially exceeded a depressed consensus while full-year sales and margin guidance remained intact, easing fears that the earnings-cut cycle had further to run.
Strong free cash flow and savings delivery provided a floor, while a weak China exit and 1–4% 2026 sales guide confirmed the lower-growth regime.
A cut to the Strategy 2028 growth algorithm and weak APAC organic sales transformed a cyclical slowdown into a more structural de-rating debate.
Sika cut its growth outlook after weak organic demand and FX, while holding the EBITDA-margin range through higher MBCC synergies and self-help.
Modest organic growth and strong Americas performance kept guidance intact, but weak Asia and a sales-only disclosure offered little proof of margin conversion.
Record EBITDA and margin confirmed synergy delivery, while the first 2025 guide of 3–6% local-currency growth reset the market below the old 6–9% algorithm.
Local-currency growth accelerated and EBITDA margin expanded sharply, validating the MBCC synergy bridge despite a still-mixed construction backdrop.